AIMA
JNJ icon

Ables Iannone Moore & Associates’s Johnson & Johnson JNJ Stock Holding History

Ables Iannone Moore & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.03M Buy
11,913
+458
+4% +$107K 1.61% 15
2026
Q1 		$2.8M Sell
11,455
-679
-6% -$158K 1.67% 14
2025
Q4 		$2.51M Sell
12,134
-375
-3% -$74.2K 1.38% 17
2025
Q3 		$2.32M Sell
12,509
-1,548
-11% -$265K 1.33% 17
2025
Q2 		$2.15M Sell
14,057
-1,424
-9% -$219K 1.34% 17
2025
Q1 		$2.57M Sell
15,481
-366
-2% -$57.3K 1.75% 15
2024
Q4 		$2.29M Sell
15,847
-107
-0.7% -$16.6K 1.41% 16
2024
Q3 		$2.59M Sell
15,954
-123
-0.8% -$19.6K 1.67% 15
2024
Q2 		$2.35M Buy
16,077
+1,711
+12% +$254K 1.55% 15
2024
Q1 		$2.27M Sell
14,366
-308
-2% -$49K 1.62% 15
2023
Q4 		$2.3M Buy
+14,674
New +$2.25M 1.75% 16

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Ables Iannone Moore & Associates's JNJ Position: Q2 2026 in Review

Ables Iannone Moore & Associates increased its Johnson & Johnson (JNJ) stake by 4% in Q2 2026, buying an estimated $107K and bringing the position to 11,913 shares worth $3.03M. The position accounts for 1.61% of the portfolio, ranked #15.

Ables Iannone Moore & Associates first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 963 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ables Iannone Moore & Associates held 11,913 shares of Johnson & Johnson worth $3.03M as of Q2 2026.
  • Ables Iannone Moore & Associates bought 458 Johnson & Johnson shares in Q2 2026, an estimated $107K.
  • Johnson & Johnson made up 1.61% of Ables Iannone Moore & Associates's portfolio in Q2 2026, its #15 holding.
  • Ables Iannone Moore & Associates first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 963 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ables Iannone Moore & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.